Abstract:Rationale: The spine is one of the most common metastatic sites of non-small cell lung cancer (NSCLC), and NSCLC spinal metastasis results in serious consequences. Metastatic extravasation of disseminated cancer cells including increased invasiveness, adhesion and transendothelial migration is crucial for tumor metastasis. This study aimed to investigate the mechanisms underlying NSCLC spinal metastasis based on the C-X3-C motif chemokine ligand 1- (CX3CL1) and intercellular adhesion molecule-1- (ICAM-1) mediated signaling network. Methods: Immunohistochemistry, western blotting, and reverse transcription-quantitative PCR were conducted to detect the distribution of CX3CL1/ICAM-1 in different organs. Transwell, adhesion, and transendothelial migration assays were performed to evaluate the regulatory effects of CX3CL1/ICAM-1 on NSCLC cell invasion, adhesion, and transendothelial migration in vitro. A spontaneous spinal metastasis mouse model was established via injection of NSCLC cells into the left cardiac ventricle of NOD/SCID mice. The effects of CX3CL1/ICAM-1 on NSCLC spinal metastasis in vivo were validated using bioluminescent, micro-computerized tomography, immunohistochemistry and histological analyses. Results: CX3CL1 expression was specifically higher in vertebral bone compared with limb bones and lung tissue, and was associated with NSCLC spinal metastasis. Mechanically, vertebral bone marrow endothelial cells (VBMECs) enhanced NSCLC cell invasion via CX3CL1 signaling-mediated activation of the PI3K/AKT pathway. Furthermore, we found that VBMECs effectively induced ICAM-1-dependent NSCLC cell adhesion in coordination with platelets through the CX3CL1/ICAM-1/LFA-1 pathway. Meanwhile, CX3CL1 enhanced NSCLC cell transendothelial migration by increasing permeability of VBMECs via ICAM-1-dependent activation of the Src/GEF-H1 pathway. Interestingly, NSCLC cells were indicated to promote CX3CL1 secretion of VBMECs through MAPK14/ADMA17-dependent CX3CL1 release and NF-κB-dependent CX3CL1 synthesis. Based on these findings, we revealed a novel feedback cycle between circulating NSCLC cells and VBMECs mediated by CX3CL1/ICAM-1 signaling. Further disengagement of the CX3CL1/ICAM-1-mediated feedback cycle in vivo significantly restricted metastasis and prolonged mouse survival. Conclusions: Our results indicated a unique feedback cycle between circulating NSCLC cells and VBMECs mediated by CX3CL1/ICAM-1 signaling, which is necessary for NSCLC spinal metastasis. This work provides a new perspective for underlying the mechanisms of NSCLC spinal metastasis and indicates potential novel targets for the prevention of NSCLC spinal metastasis.

Vertebral-specific Activation of the CX3CL1/ICAM-1 Signaling Network Mediates Non-Small-cell Lung Cancer Spinal Metastasis by Engaging Tumor Cell-Vertebral Bone Marrow Endothelial Cell Interactions.

CX3CL1 Induces Vertebral Microvascular Barrier Dysfunction Via the Src/P115-RhoGEF/ROCK Signaling Pathway

CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.

CX3CL1 in the Red Bone Marrow Promotes Renal Cell Carcinoma to Metastasize to the Spine by Involving the Src-related Pathway.

CX3CL1: a Potential Chemokine Widely Involved in the Process Spinal Metastases

In Vivo Selection for Spine-Derived Highly Metastatic Lung Cancer Cells is Associated with Increased Migration, Inflammation and Decreased Adhesion

ADAM17-regulated CX3CL1 Expression Produced by Bone Marrow Endothelial Cells Promotes Spinal Metastasis from Hepatocellular Carcinoma

CXCR4 is Involved in CD133-induced EMT in Non-Small Cell Lung Cancer.

Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation

Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis

CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway

A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner

Siglec15 Facilitates the Progression of Non-Small Cell Lung Cancer and is Correlated with Spinal Metastasis.

Breast Cancer-Derived CAV1 Promotes Lung Metastasis by Regulating Integrin Α6β4 and the Recruitment and Polarization of Tumor-Associated Neutrophils

Paracrine signaling by VEGF-C promotes non-small cell lung cancer cell metastasis via recruitment of tumor-associated macrophages.

M2‐like Macrophage‐derived Exosomes Facilitate Metastasis in Non‐small‐cell Lung Cancer by Delivering Integrin Αvβ3

XCR1 Promotes Cell Growth and Migration and is Correlated with Bone Metastasis in Non-Small Cell Lung Cancer.

CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10

Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma

Lymphatic Endothelial Cell-Secreted Cxcl1 Stimulates Lymphangiogenesis and Metastasis of Gastric Cancer

Single-Cell Map of Diverse Immune Phenotypes in the Metastatic Brain Tumor Microenvironment of Non Small Cell Lung Cancer